FDA
approval
· 2017-12-21
FDA Approved: GIAPREZA — Original Application (La Jolla Pharmaceutical Company)
Summary
GIAPREZA (angiotensin II) was approved to increase blood pressure in adults with septic or other distributive shock.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for GIAPREZA (ANGIOTENSIN II)